Anpac Bio has partnerships with more than 140 major hospitals and clinical testing centers, and over 200 science, technology, government, nonprofit, educational, and advocacy organizations, worldwide. Among them:
RESEARCH AND CLINICAL TRIALS
Anpac Bio is working with internationally-respected medical institutions to develop R&D investigations and formal clinical trials in the United States. These trials are in addition to the 35,000 cases that have successfully been conducted globally.
OTHER SCREENING AND DETECTION SERVICES
In addition to Anpac Bio’s proprietary CDA medical devices, the company is developing a multitude of disease screening and detection services, reagents, testing processing and services, data management, consulting services, and innovative health-related training and technology.